The Drug Controller General of India (DCGI) has given conditional market approval to companies for Covishield and Covaxin. But the vaccine will not be available at the medical store. Vaccines can be purchased from hospitals and clinics only. Vaccination data has to be submitted to DCGI every six months. The data will also be updated on the Covin app.
India's drug regulator on Thursday approved the regular sale of the Covid 19 vaccines Covishield and Covaxin for use in the adult population, subject to certain conditions. Approval has been given under the New Drugs and Clinical Trials Rules, 2019. Under the conditions, firms will submit data on vaccines to be supplied for ongoing clinical trials and programmatic settings. Monitoring for any adverse event will continue after vaccination.
Mansukh Mandaviya also gave information
At the same time, Union Health Minister Dr. Mansukh Mandaviya said that the Central Drugs Standard Control Organization (CDSCO) has now upgraded the permission of Covaxin and Covishield from restricted use in emergencies to the permission of generic new drugs in the adult population with certain conditions.
was recommended on January 19
Serum Institute of India (SII) for use in an adult population subject to certain conditions after approval of Drug Controller General of India (DCGI) by Subject Expert Committee (SEC) on COVID-19 of Central Drugs Standard Control Organization (CDSCO) on 19 Jan. K Covishield and Bharat Biotech's Covaxin were recommended for approval for regular market sale.
Both companies had submitted data and information
On October 25, Prakash Kumar Singh, director of government and regulatory affairs at SII, had submitted an application to DCGI seeking permission to sell Covishield in the market regularly. Singh had recently submitted more data and documents after DCGI had sought more data and documents from the Pune-based company. He had said that such large-scale vaccination and prevention of corona infection with Covidshield is in itself proof of the safety and efficacy of the vaccine.
Meanwhile, in an application sent to DCGI, V Krishna Mohan, the whole-time director at Hyderabad-based Bharat Biotech, had submitted clinical data as well as complete details of chemistry, manufacturing, and control, seeking approval to launch Covaxin.
First Indian visit today after the Taliban government took over Afghanistan
India's delegation is going to Kabul on Thursday for the first time since the Taliban took power
Sunrisers Hyderabad defeated Lucknow Super Giants by six wickets on Monday in IPL 2025. In this m
Pakistan is not deterring from its nefarious antics. After hurling an IED tiffin bomb from a dron
In an important decision, the Supreme Court has strictly ordered social media influencer, famous
PM's letter to Kovind: 'It's a privilege to work with you, PM's letter touched Kovind's heart
Prime Minister Narendra Modi has written a letter praising former President Ram Nath Kovind. PM M
Nursing Courses Admission: The Supreme Court on Friday refused to direct the Center and the India
Selective criticism of the judiciary in matters involving politicians is not good for democracy.
These days a special change is being seen in the weather. Snowfall started in the mountains. It i
Haryana Government has banned stone crushers in the area adjoining Delhi. The Haryana government
Sitharaman visits National Science Foundation in Washington, professors gave presentations
Union Finance Minister Nirmala Sitharaman visited the National Science Foundation Headquarters (N
